$SEM

Ely James S. III sold (to issuer) $2.7M of SEM

Ely James S. III sold (to issuer) 161,674 shares of SELECT MEDICAL HOLDINGS CORP (SEM) at $16.50 ($2.67M total) on 2026-06-30.

Original reporting
SEC EDGAR · Ely James S. III
Published Jul 1, 2026, 6:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SEM
Neutral
high confidence
Mentioned
$SEM
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEMNeutralLow
01

Why it matters

The newest disclosed fact is the director’s sale to the issuer (likely buyback participation) at a specific price and the resulting 0-share holding.

02

Market read

This provides incremental positioning information (insider exited the position) but no new company-specific fundamentals.

03

What to watch

No 10b5-1 plan is stated; however, the filing still lacks any accompanying explanation, so traders should avoid over-interpreting intent from a single transaction.

Relevance 6/10Novelty 3/10Timing: today’s SEC Form 4 filing (filed 2026-07-01)

Background

The article is an SEC Form 4 insider transaction disclosure for Select Medical Holdings (SEM).

Company-level read

Ticker impact

$SEMNeutralHigh confidence
Context

Select Medical Holdings director Ely James S. III sold 161,674 shares to the issuer on 2026-06-30 at $16.50/share per Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

This is a Form 4 insider transaction without new operating, guidance, or regulatory information; the disclosed fact is the sale size/price and post-transaction holdings (0 shares).

Market effects

Minimal; insider sale does not change sector fundamentals for healthcare services/rehab providers.

None indicated.

None indicated.

Counterpoint

Because the sale is coded as “sale to issuer,” it may reflect mechanical buyback participation rather than a bearish view on the business.

Key entities

  • SELECT MEDICAL HOLDINGS CORP

    Company whose director insider transaction is disclosed on Form 4.

  • Ely James S. III

    Director who sold 161,674 shares to the issuer on 2026-06-30.

Related articles

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.